NCT02731833View on ClinicalTrials.gov

Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

PHASE4CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

May 1, 2016

Study Completion Date

May 20, 2016

Conditions
Dentin Sensitivity
Interventions
OTHER

stannous fluoride

0.454% weight by weight (w/w) stannous fluoride containing 1100ppm fluoride

OTHER

sodium monofluorophosphate

0.76% w/w sodium monofluorophosphate containing 1000ppm fluoride

Trial Locations (1)

L4W 0C2

GSK Investigational Site, Mississauga

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02731833 - Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity | Biotech Hunter | Biotech Hunter